Key Takeaways Shares of an AI software giant tumbled on Tuesday, Nov. 4, 2025, even after its earnings report revealed solid growth, while a fast-food company benefitted from strong quarterly results.
After Pfizer agreed to acquire weight-loss drug developer Metsera for $7.3 billion, Novo Nordisk swooped in with an ...
New option listings for November 4th include DuPont de Nemours (DD), Roundhill Gold Miners WeeklyPay ETF (GDXW), and World Gold Trust (GLDW).
TD Cowen analyst Tyler Van Buren initiated coverage on MBX Biosciences, Inc. (NASDAQ: MBX) with a Buy rating. MBX Biosciences ...
The Morning Bull - US Market Morning Update Tuesday, Nov, 4 2025 US stock futures are sliding premarket as investors digest ...